Clinical Trial Update: Safety and Efficacy Study of IMM 124-E (Bovine Colostrum) for Patients With Nonalcoholic Steatohepatitis [Phase 2]

View source ↗

Summary

A Phase 2 safety and efficacy trial of IMM 124-E (bovine colostrum) for nonalcoholic steatohepatitis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Steatohepatitis

Drugs mentioned

• IMM 124-E (bovine colostrum)

Snippet

Sponsor: Immuron Ltd. | Conditions: Nonalcoholic Steatohepatitis | Phase 2 | Status: WITHDRAWN